Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

capecitabine/methotrexate/vinorelbine regimen

A regimen composed of capecitabine, methotrexate and vinorelbine that can potentially be used in the treatment of breast cancer.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	capecitabine-methotrexate-vinorelbine regimen capecitabine/methotrexate/vinorelbine tartrate regimen Xeloda-methotrexate-navelbine regimen Xeloda/methotrexate/navelbine regimen XMV regimen

capecitabine/methotrexate/vinorelbine regimen

Search NCI's Drug Dictionary